Among mapped households, a total of 1055 Maindi villagers participated in at least one examination during this study: 865 (865/1055, 82%) participated at baseline, with an additional 190 (190/1055, 18%) villagers participating in at least one follow-up examination. Of those participating in at least one follow-up, but not the baseline examination, 117 (117/190, 61.6%) were part of the baseline census; 73 (73/190, 38.4%) joined the study after baseline. There were 851 (851/1055 80.7%) who received treatment at baseline.
There was a total of 374 (374/1055, 35.4%) villagers who were children younger than 8 years: 269 (269/374, 71.9%) participated at baseline, with an additional 105 children (105/374, 28.1%) coming to at least one of the follow-up examinations. There were 260 children (260/269, 96.7%) who participated in baseline and received treatment; however, among those participating after baseline, only 14 (14/105, 13.3%) had received treatment. The median load of infection in children with laboratory-positive tests was 19.1 copies/swab at baseline. The proportion of children with laboratory-positive tests and high ocular chlamydia loads (loads higher than the median) dropped after baseline treatment, but rates of active trachoma dropped less radically
(Table 1) . The proportion of laboratory-positive children dropped 46.9% (
P < 0.0001) between baseline and 2 months, remained approximately the same between 2 and 6 months (
P = 0.25), dropped again between 6 and 12 months (
P = 0.0001), and rose a little between 12 and 18 months (
P = 0.052). The 6- and 18-month time periods corresponded with the rainy season, so this may account for some of the variability in ocular chlamydia prevalence. The rates of active trachoma dropped 15.2% (
P = 0.0003) between baseline and 2 months but remained approximately the same thereafter.
The total number of households was 215, with 175 (175/215, 81.4%) households having at least one child; among these households, the average number of children was 2.2, with a range of 1–5. Of the households with children, 127 (127/175, 72.6%) had at least one child with a laboratory-positive test at some point in time. There were 87 (87/175, 49.7%) households with 100% of children having treatment; 147 (147/175, 84.0%) households with at least 50% of the children having treatment, and 24 (24/175, 13.7%) had no children treated. The proportion of households with laboratory-positive children dropped after baseline treatment, and the proportion of households with children having active trachoma dropped as well
(Table 2) . Among households with laboratory-positive children, mean household loading of ocular chlamydia at baseline had a median of 32.4 copies/swab and IQR of [5.7, 1336.3] copies/swab. At the 2-month follow-up, the median average household load was only 10.1 copies/swab with IQR, [2.4, 215.2], among households with laboratory-positive children.
Figures 1a 1b 1c 1d 1eshow the relative locations of all 175 households in Maindi that had children living in them. Households considered to have high ocular chlamydia loads are shown in red. At baseline
(Fig. 1a) , 43% of households were considered to have high loads. This was reduced after treatment with azithromycin to 13% 2 months after treatment
(Fig. 1b) , 20% at 6 months
(Fig. 1c) , 9.5% at 12 months
(Fig. 1d) , and 24.3% at 18 months
(Fig. 1e) . As can be seen at the baseline and follow-up maps, much of the ocular chlamydia was reduced in children using mass treatment. HL households (i.e., average household loading was 32.4 copies/swab or higher) remained in the following months, but overall rates of households with laboratory-positive children remained lower than baseline rates
(Table 2) .
Clustering of HL households occurred at distances <2 km, at baseline
(Fig. 2a) . Two months after treatment, there was no difference in clustering of HL or LL households
(Fig. 2b) ; and at 6 months, slight clustering existed within 0.5 km
(Fig. 2c) . At 12 and 18 months, there was clustering of HL households, for distances < 1.3 km
(Figures 2d 2e) . Although laboratory-positive test rates and ocular chlamydia loading did not return to baseline levels by 18 months, HL households did cluster together at distances close to what was found at baseline, suggesting that households with high loading spread ocular chlamydia to nearby homes by 18 months.
Other household outcomes were examined for spatial clustering: households with at least one child with a laboratory-positive test and households with any active trachoma in children. Among households with at least one child with a laboratory-positive test, there was significant clustering at baseline, similar to the difference in k-functions shown in
Figure 2 . However, at 6 and 12 months, the clustering among households with at least one child with a laboratory-positive test was borderline significant at distances up to 1 km, and, at 18 months, showed similar clustering to HL households. No clustering effects were seen for households with active trachoma. Households with larger numbers of children might have increased risk of recurrent infection; however, we found no clustering of households with larger numbers of children (1 or 2 children versus 3 or more).